Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.36 |
| ▸ | BCHE | P06276 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 2/20 | 0.35 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.34 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23722165 | 0.99 | SMYD3 (0.36) | SMYD3CHRM4BCHEACHEALDH1A1 | |
| SCHEMBL23745500 | 0.90 | CHRM4 (0.38) | SMYD3CHRM4BCHEACHEALDH1A1 | |
| Hydrochloric Acid SCHEMBL23721878 | 0.89 | CHRM4 (0.38) | SMYD3CHRM4BCHEACHEALDH1A1 | |
| SCHEMBL23745676 | 0.86 | ALDH1A1 (0.39) | SMYD3CHRM4BCHEACHEALDH1A1 | |
| SCHEMBL23745452 | 0.86 | BCHE (0.42) | BCHEACHEALDH1A1BRD4ITGB3 | |
| Hydrochloric Acid SCHEMBL23722185 | 0.86 | ALDH1A1 (0.39) | SMYD3CHRM4BCHEACHEALDH1A1 | |
| Hydrochloric Acid SCHEMBL22439438 | 0.85 | BCHE (0.42) | BCHEACHEALDH1A1BRD4ITGB3 | |
| SCHEMBL23745494 | 0.83 | CHRM4 (0.38) | SMYD3CHRM4BCHEACHEALDH1A1 | |
| SCHEMBL23745466 | 0.82 | ALDH1A1 (0.39) | SMYD3BCHEACHEALDH1A1BRD4 | |
| Hydrochloric Acid SCHEMBL23722164 | 0.82 | CHRM4 (0.38) | SMYD3CHRM4BCHEACHEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | BIOIMICS AB (SE) | 2021-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | FDPS, FPR1, F12 | SMYD3 3773/4885CHRM4 4061/4885BCHE 953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.